Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ginkgo biloba prevention trial in older individuals

Next Previous
Trial Profile

Ginkgo biloba prevention trial in older individuals

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Therapeutic Use
  • Acronyms GEM

Most Recent Events

  • 01 Nov 2010 Planned end date changed from 1 Jul 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.
  • 01 Nov 2010 Planned end date changed from 1 Jul 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.
  • 23 Dec 2009 Primary endpoint results published in the JAMA: the Journal of the American Medical Association 302: 2663-70, No. 24, 23 Dec 2009

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top